| Name | Orelabrutinib |
|---|
| Description | Orelabrutinib (ICP-022) is a potent, orally active, and irreversible Bruton's tyrosine kinase (BTK) inhibitor. Orelabrutinib has the potential for B-cell malignancies treatment[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C26H25N3O3 |
|---|---|
| Molecular Weight | 427.50 |